Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11801601rdf:typepubmed:Citationlld:pubmed
pubmed-article:11801601lifeskim:mentionsumls-concept:C0026336lld:lifeskim
pubmed-article:11801601lifeskim:mentionsumls-concept:C0036751lld:lifeskim
pubmed-article:11801601lifeskim:mentionsumls-concept:C0034838lld:lifeskim
pubmed-article:11801601lifeskim:mentionsumls-concept:C1704675lld:lifeskim
pubmed-article:11801601lifeskim:mentionsumls-concept:C0018882lld:lifeskim
pubmed-article:11801601lifeskim:mentionsumls-concept:C1314939lld:lifeskim
pubmed-article:11801601lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:11801601lifeskim:mentionsumls-concept:C0332120lld:lifeskim
pubmed-article:11801601lifeskim:mentionsumls-concept:C0332453lld:lifeskim
pubmed-article:11801601lifeskim:mentionsumls-concept:C0442821lld:lifeskim
pubmed-article:11801601pubmed:issue13lld:pubmed
pubmed-article:11801601pubmed:dateCreated2002-3-25lld:pubmed
pubmed-article:11801601pubmed:abstractText5-Hydroxytryptamine 2A (5-HT2A) receptors are essential for the actions of serotonin (5-hydroxytryptamine (5-HT)) on physiological processes as diverse as vascular smooth muscle contraction, platelet aggregation, perception, and emotion. In this study, we investigated the molecular mechanism(s) by which 5-HT activates 5-HT2A receptors using a combination of approaches including site-directed mutagenesis, molecular modeling, and pharmacological analysis using the sensitive, cell-based functional assay R-SAT. Alanine-scanning mutagenesis of residues close to the intracellular end of H6 of the 5-HT2A receptor implicated glutamate Glu-318(6.30) in receptor activation, as also predicted by a newly constructed molecular model of the 5-HT2A receptor, which was based on the x-ray structure of bovine rhodopsin. Close examination of the molecular model suggested that Glu-318(6.30) could form a strong ionic interaction with Arg-173(3.50) of the highly conserved "(D/E)RY motif" located at the interface between the third transmembrane segment and the second intracellular loop (i2). A direct prediction of this hypothesis, that disrupting this ionic interaction by an E318(6.30)R mutation would lead to a highly constitutively active receptor with enhanced affinity for agonist, was confirmed using R-SAT. Taken together, these results predict that the disruption of a strong ionic interaction between transmembrane helices 3 and 6 of 5-HT2A receptors is essential for agonist-induced receptor activation and, as recently predicted by ourselves (B. L. Roth and D. A. Shapiro (2001) Expert Opin. Ther. Targets 5, 685-695) and others, that this may represent a general mechanism of activation for many, but not all, G-protein-coupled receptors.lld:pubmed
pubmed-article:11801601pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11801601pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11801601pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11801601pubmed:languageenglld:pubmed
pubmed-article:11801601pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11801601pubmed:citationSubsetIMlld:pubmed
pubmed-article:11801601pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11801601pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11801601pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11801601pubmed:statusMEDLINElld:pubmed
pubmed-article:11801601pubmed:monthMarlld:pubmed
pubmed-article:11801601pubmed:issn0021-9258lld:pubmed
pubmed-article:11801601pubmed:authorpubmed-author:ShapiroDavid...lld:pubmed
pubmed-article:11801601pubmed:authorpubmed-author:KristiansenKu...lld:pubmed
pubmed-article:11801601pubmed:authorpubmed-author:WeinerDavid...lld:pubmed
pubmed-article:11801601pubmed:authorpubmed-author:KroezeWesley...lld:pubmed
pubmed-article:11801601pubmed:authorpubmed-author:RothBryan LBLlld:pubmed
pubmed-article:11801601pubmed:issnTypePrintlld:pubmed
pubmed-article:11801601pubmed:day29lld:pubmed
pubmed-article:11801601pubmed:volume277lld:pubmed
pubmed-article:11801601pubmed:ownerNLMlld:pubmed
pubmed-article:11801601pubmed:authorsCompleteYlld:pubmed
pubmed-article:11801601pubmed:pagination11441-9lld:pubmed
pubmed-article:11801601pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:11801601pubmed:meshHeadingpubmed-meshheading:11801601...lld:pubmed
pubmed-article:11801601pubmed:meshHeadingpubmed-meshheading:11801601...lld:pubmed
pubmed-article:11801601pubmed:meshHeadingpubmed-meshheading:11801601...lld:pubmed
pubmed-article:11801601pubmed:meshHeadingpubmed-meshheading:11801601...lld:pubmed
pubmed-article:11801601pubmed:meshHeadingpubmed-meshheading:11801601...lld:pubmed
pubmed-article:11801601pubmed:meshHeadingpubmed-meshheading:11801601...lld:pubmed
pubmed-article:11801601pubmed:meshHeadingpubmed-meshheading:11801601...lld:pubmed
pubmed-article:11801601pubmed:meshHeadingpubmed-meshheading:11801601...lld:pubmed
pubmed-article:11801601pubmed:meshHeadingpubmed-meshheading:11801601...lld:pubmed
pubmed-article:11801601pubmed:meshHeadingpubmed-meshheading:11801601...lld:pubmed
pubmed-article:11801601pubmed:year2002lld:pubmed
pubmed-article:11801601pubmed:articleTitleEvidence for a model of agonist-induced activation of 5-hydroxytryptamine 2A serotonin receptors that involves the disruption of a strong ionic interaction between helices 3 and 6.lld:pubmed
pubmed-article:11801601pubmed:affiliationDepartment of Biochemistry, Case Western Reserve University Medical School, Cleveland, Ohio 44106-4935, USA.lld:pubmed
pubmed-article:11801601pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11801601pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:11801601pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:15558entrezgene:pubmedpubmed-article:11801601lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:11801601lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11801601lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11801601lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11801601lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11801601lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11801601lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11801601lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11801601lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11801601lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11801601lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11801601lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11801601lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11801601lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11801601lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11801601lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11801601lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11801601lld:pubmed